doi:10.3969/j.issn.1671-2587.2021.01.030

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2021, Vol. 23 ›› Issue (1): 116-122.DOI: 10.3969/j.issn.1671-2587.2021.01.030

Previous Articles Next Articles

Received:2020-06-19 Published:2021-02-22

[1] WHO.Blood safety and availability[EB/OL].(2020-06-10).https://www.who.int/news-room/fact-sheets/detail/blood-safety-and-availability.
[2] EDER A,GOLDMAN M,ROSSMANN S,et al.Selection criteria to protect the blood donor in north America and Europe:past (dogma),present (evidence),and future (hemovigilance)[J].Transfus Med Rev,2009,23(3):205-220.
[3] 张美萍.陈书芳.周秀英.等. 浅谈如何做好暂缓延期献血者的招募[J]. 临床输血与检验,2010,12(4):354-355.
[4] SHI L,WANG J X,LIU Z,et al.Blood donor management in China[J].Transfus Med Hemother,2014,41(4):273-282.
[5] WHO.Blood donor selection:guidelines on assessing donor suitability for blood donation[EB/OL].(2012). https://apps.who.int/iris/handle/10665/76724.
[6] LEVITT J.Standards for blood banks and transfusion services[M].29th Edition.,Bethesda,AABB,2014.
[7] MOLONEY W C,LONNERGAN L R,MCCLINTOCK J K.Syncope in blood donors[J].N Engl J Med,1946,234(4):114-118.
[8] NEWMAN B H,SATZ S L,JANOWICZ N M,et al.Donor reactions in high-school donors:the effects of sex,weight,and collection volume[J].Transfusion,2006,46(2):284-288.
[9] EDER A F.Adverse reactions to allogeneic whole blood donation by 16-and 17-year-olds[J].JAMA,2008,299(19):2279.
[10] NISHIMORI H,FUJII N,FUJII K,et al.Predictors of vasovagal reactions during preoperative autologous blood donation:a single-institution analysis[J].Int J Hematol,2017,105(6):812-818.
[11] GOLDMAN M,OSMOND L,YI Q L,et al.Frequency and risk factors for donor reactions in an anonymous blood donor survey[J].Transfusion,2013,53(9):1979-1984.
[12] SALVADORI U,SANDRI M,CEMIN R,et al.Effect of a liberal versus a restrictive pre-donation blood pressure policy on whole-blood donor adverse reactions[J].Vox Sang,2019,114(4):317-324.
[13] FRANCE C R,FRANCE J L.Estimating the risk of blood donation fainting for self versus others:the mod-erating effect of fear[J].Transfusion,2019,59(6):2039-2045.
[14] 张燕华,戴梓宁,王同显.延长法定献血年龄的安全性和可行性[J].中国输血杂志,2020,33(2):172-175.
[15] EDER A F,DY B A,KENNEDY J M,et al.The American Red Cross donor hemovigilance program:complications of blood donation reported in 2006[J].Transfusion,2008,48(9):1809-1819.
[16] SHEHATA N,KUSANO R,HANNACH B,et al.Reacti-on rates in allogeneic donors[J].Transfus Med,2004, 14(5):327-333.
[17] TAKANASHI M,ODAJIMA T,AOTA S,et al.Risk factor analysis of vasovagal reaction from blood donation[J].Transfus Apher Sci,2012,47(3):319-325.
[18] ZEILER T,LANDER-KOX J,ALT T.Blood donation by elderly repeat blood donors[J].Transfus Med Hemotherapy,2014,41(4):242-250.
[19] GOLDMAN M,GERMAIN M,GRÉGOIRE Y,et al.Safety of blood donation by individuals over age 70 and their contribution to the blood supply in five developed countries:a BEST Collaborative group study[J].Transfusion,2019,59(4):1267-1272.
[20] WILTBANK T B,GIORDANO G F,KAMEL H,et al.Faint and prefaint reactions in whole-blood donors:an analysis of predonation measurements and their predictive value[J].Transfusion,2008,48(9):1799-1808.
[21] THIJSEN A,MASSER B.Vasovagal reactions in blood donors:risks,prevention and management[J].Transfus Med,2017,29:13-22.
[22] RIGA A,SAPEY T,BACANU M,et al.Blood donors- Serious adverse reactions(SAR)2010-2014 EFS Châteauroux,France[J].Transfus Clinique et Biol,2015,22(2):62-65.
[23] TONDON R,PANDEY P,CHAUDHARY R.Vasovagal reactions in 'at risk' donors:a univariate analysis of effect of age and weight on the grade of donor reactions[J].Transfus Apher Sci,2008,39(2):95-99.
[24] WIERSUM-OSSELTON J C,MARIJT-VAN DER KREEK T,BRAND A,et al.Risk factors for complications in donors at first and repeat whole blood donation:a cohort study with assessment of the impact on donor return[J].Blood Transfus,2014,12 Suppl 1:s28-s36.
[25] EDER A,KAMEL H,FRANCE C,et al,Appendix 1 Recommendations to minimize the risk of reactions and injuries amongadolescent blood donors[C]. Bethesda,MD,AABB:2008.
[26] EDER A F,DY B A,KENNEDY J M,et al.Improved safety for young whole blood donors with new selection criteria for total estimated blood volume[J].Transfusion,2011,51(7):1522-1531.
[27] PEREZ G E,GAMMON R R,WHITAKER B I,et al.Impact of changes to donor hemoglobin criteria on the rate of donor deferral[J].Transfusion,2018,58(11):2581-2588.
[28] OFFICE OF THE FEDERAL REGISTER,NATIONAL ARCHIVES AND RECORDS ADMINISTRATION. Requirements for blood and blood components intended for transfusion or for further manufacturing use[EB/OL].(2015-05-22). https://www.govinfo.gov/app/details/FR-2015-05-22/2015-12228.
[29] BEUTLER E,WAALEN J.The definition of anemia:what is the lower limit of normal of the blood hemoglobin concentration?[J].Blood,2006,107(5):1747-1750.
[30] PI D W,KRIKLER S H,SPARLING T G,et al.Reappraisal of optimal hemoglobin standards for female blood donors in Canada[J].Transfusion,1994,34(1):7-10.
[31] GAMMON R R,KOZEL T,MOREL P,et al.Evaluation of iron stores by zinc protoporphyrin analysis in blood donors[J].Lab Med,2018,49(4):311-315.
[32] GYBEL-BRASK M,SEEBERG J,THOMSEN L L,et al.Intravenous iron isomaltoside improves hemoglobin concentration and iron stores in female iron-deficient blood donors:a randomized double-blind placebo-controlled clinical trial[J].Transfusion,2018,58(4):974-981.
[33] SIMON T L.Iron stores in blood donors[J].JAMA:J Am Med Assoc,1981,245(20):2038.
[34] BAART A M,VAN DEN HURK K,DE KORT W L A M.Minimum donation intervals should be reconsidered to decrease low hemoglobin deferral in whole blood donors:an observational study[J].Transfusion,2015,55(11):2641-2644.
[35] MANASCERO-GÓMEZ A R,BRAVO-ESPINOSA M,SOLANO-MURIEL K,et al.Influence of blood donation time intervals on ferritin and hemoglobin concentration[J].Transfus Apher Sci,2015,53(2):213-219.
[36] SCHOTTEN N,PASKER-DE JONG P C M,MORETTI D,et al.The donation interval of 56 days requires extension to 180 days for whole blood donors to recover from changes in iron metabolism[J].Blood,2016,128(17):2185-2188.
[37] OFFICE OF THE FEDERAL REGISTER, NATIONAL ARCHIVES AND RECORDS ADMINISTRATION.Requirements for Human Blood and Blood Components Intended for Transfusion or for Further Manufacturing Use[EB/OL].(2007-11-08). https://www.govinfo.gov/app/details/FR-2007-11-08/E7-21565.
[38] Atherosclerosis,Hypertension,and Obesity in the Young Committee of the American Heart Association Council on Cardiovascular Disease in the Young,ALPERT B,MCCRINDLE B,et al.Recommend-ations for blood pressure measurement in humanAtherosclerosis,Hypertension,and Obesity in the Young Committee of the American Heart Association Council on Cardiovascular Disease in the Young,ALPERT B,MCCRINDLE B,Recommend-ations for blood pressure measurement in human and experimental animals;part 1:blood pressure measurement in humans[J]. Hypertension,2006;48:e3; author reply e5.
[39] ARAM V CHOBANIAN,GEORGE L BAKRIS, HEN-RY R BLACK,et al.Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure[J]. Hypertension, 2003,42(6):1206-1252.
[40] TIERNEY W M.Quantifying risk of adverse clinical events with one set of vital signs among primary care patients with hypertension[J].Ann Fam Med,2004,2(3):209-217.
[41] GERMAIN M,DELAGE G,GRÉGOIRE Y,et al. Donation by donors with an atypical pulse rate does not increase the risk of cardiac ischaemic events[J].Vox Sang,2013,104(4):309-316.
[42] MANN M,SACKS H J,GOLDFINGER D.Safety of autologous blood donation prior to elective surgery for a variety of potentially ''high-risk'' patients[J].Transfusion,1983,23(3):229-232.
[43] KLAPPER E,PEPKOWITZ S H,CZER L,et al.Con-firmation of the safety of autologous blood donation by patients awaiting heart or lung transplantation:a controlled study using hemodynamic monitoring[J].J Thorac Cardiovasc Surg,1995,110(6):1594-1599.
[44] EDER A,BIANCO C.Screening blood donors:Scien ce,reason,and the donor history questionnaire[C]. Bethesda:American Association of Blood Banks; 2007,11-16.
[45] EDGREN G,HJALGRIM H,REILLY M,et al.Risk of cancer after blood transfusion from donors with subclinical cancer:a retrospective cohort study[J].Lancet,2007,369(9574):1724-1730.
[46] QIUPING GU,RYNE PAULOSE-RAM,CHARLES DILLON,et al.Antihypertensive Medication Use Among US Adults with Hypertension[J].Circulation,2006,113(2):213-221.
[47] GOLDMAN M,W-Y SHIH A,O'BRIEN SF,et al. Donor deferral policies for men who have sex with men: past, present and future[J]. Vox Sang. 2018,113(2):95-103.

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

About

Author

Journal

Access Statistics

Contact

[1]	JIA Yan-jun, ZHAO Xu-ying, WEI Zhen-zhen. Effects of Resveratrol on Platelet Oxidative Stress and Aging Index and Storage Time [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 137-141.
[2]	WANG Hui-ru, LIU Hui-lan. Factors Influencing Blood Transfusion in Patients after Unrelated Umbilical Cord Blood Transplantation [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 162-166.
[3]	ZHANG Yuan-yuan, YING Mei-ai, PAN Jian, et al. The Clinical Effect of Plasma Exchange in ABO Incompatible Relatives in vivo Kidney Transplantation [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 167-172.
[4]	WANG Lei, WU Xue-zhong. Retrospective Analysis of Rh (D,C, c, E, e) Antigens Compatibility between Blood Recipients and Donors [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 181-185.
[5]	GAN Shan, DUAN Ling, HU Hong-bing. The Clinical Use of Blood in Exchange Transfusion for Severe Neonatal Hyperbilirubinemia [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 185-188.
[6]	DUAN Bing-zheng, WANG Shu-lian, LIAN Jun-hui, et al. Clinical Significance of Direct Anti-human Globulin Test in Patients' Blood Transfusion Effect [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 189-191.
[7]	YANG Chun-chen, RONG Rui-ming, LI Yang, et al. An Evaluation Model of Clinical Blood Transfusion Records Based on Cov-AHP-fuzzy Comprehensive Evaluation Method [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 192-196.
[8]	GUO Wei-jie, LIU Ze-ya, ZHANG Fan, et al. Meta-analysis：Unexpected Antibody Positive Rate of Blood Donors in China [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 202-212.
[9]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 236-239.
[10]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 239-241.
[11]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 248-255.
[12]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 259-262.
[13]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 268-272.
[14]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(1): 13-17.
[15]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(6): 587-589.